Serine-Arginine Protein Kinase 1 Regulates Ebola Virus Transcription.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
25 02 2020
Historique:
entrez: 27 2 2020
pubmed: 27 2 2020
medline: 25 8 2020
Statut: epublish

Résumé

Ebola virus (EBOV) causes a severe and often fatal disease for which no approved vaccines or antivirals are currently available. EBOV VP30 has been described as a viral phosphoprotein, and nonphosphorylated VP30 is essential and sufficient to support secondary transcription in an EBOV-specific minigenome system; however, phosphorylatable serine residues near the N terminus of VP30 are required to support primary viral transcription as well as the reinitiation of VP30-mediated transcription at internal EBOV genes. While the dephosphorylation of VP30 by the cellular phosphatase PP2A was found to be mediated by nucleoprotein, the VP30-specific kinases and the role of phosphorylation remain unknown. Here, we report that serine-arginine protein kinase 1 (SRPK1) and SRPK2 phosphorylate serine 29 of VP30, which is located in an N-terminal R

Identifiants

pubmed: 32098814
pii: mBio.02565-19
doi: 10.1128/mBio.02565-19
pmc: PMC7042693
pii:
doi:

Substances chimiques

Nucleoproteins 0
RNA, Viral 0
Transcription Factors 0
Viral Proteins 0
SRPK1 protein, human EC 2.7.1.-
Protein Serine-Threonine Kinases EC 2.7.11.1
SRPK2 protein, human EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 Takamatsu et al.

Références

PLoS Negl Trop Dis. 2010 Aug 24;4(8):e802
pubmed: 20808767
J Biol Chem. 2002 Sep 6;277(36):33099-104
pubmed: 12052831
J Mol Cell Cardiol. 2016 Dec;101:127-133
pubmed: 27832939
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Gen Virol. 2010 May;91(Pt 5):1325-34
pubmed: 20071483
J Virol. 2002 Sep;76(17):8532-9
pubmed: 12163572
PLoS Pathog. 2016 Oct 18;12(10):e1005937
pubmed: 27755595
Curr Opin Chem Biol. 2017 Aug;39:126-132
pubmed: 28732278
Virology. 1985 Nov;147(1):169-76
pubmed: 4060597
J Virol. 2007 Jun;81(11):5437-48
pubmed: 17360743
J Virol. 2004 Nov;78(22):12277-87
pubmed: 15507615
RNA Biol. 2016 Sep;13(9):783-98
pubmed: 27315567
J Biol Chem. 2004 Jul 30;279(31):32426-34
pubmed: 15155723
Virology. 2017 Dec;512:39-47
pubmed: 28915404
J Virol. 2014 Nov;88(21):12599-611
pubmed: 25142587
Expert Rev Anti Infect Ther. 2018 Jan;16(1):67-76
pubmed: 29210303
J Virol. 2002 Aug;76(16):8124-37
pubmed: 12134018
Electrophoresis. 1999 Dec;20(18):3551-67
pubmed: 10612281
J Virol. 2006 Jul;80(14):7260-4
pubmed: 16809331
Methods Mol Biol. 2017;1628:119-131
pubmed: 28573615
Antiviral Res. 2011 Aug;91(2):195-208
pubmed: 21699921
Biochimie. 2007 Jan;89(1):39-47
pubmed: 16996192
EMBO J. 2003 Apr 1;22(7):1608-19
pubmed: 12660167
Virology. 2010 Jul 20;403(1):56-66
pubmed: 20444481
J Virol. 2010 Aug;84(15):7847-56
pubmed: 20504928
Curr Opin Virol. 2012 Oct;2(5):614-21
pubmed: 23057872
J Virol. 2002 Apr;76(7):3461-70
pubmed: 11884570
J Biol Chem. 2014 Aug 15;289(33):22723-38
pubmed: 24936058
PLoS Pathog. 2012;8(8):e1002847
pubmed: 22876185
J Virol. 1999 Mar;73(3):2333-42
pubmed: 9971816
J Virol. 2010 Jul;84(14):7053-63
pubmed: 20463076
Nat Commun. 2017 Jun 08;8:15576
pubmed: 28593988
J Biol Chem. 2013 Apr 19;288(16):11165-74
pubmed: 23493393
Chemistry. 2004 Sep 6;10(17):4233-9
pubmed: 15352106
Mol Cell. 2018 Jan 4;69(1):136-145.e6
pubmed: 29290611
Cell Microbiol. 2012 Feb;14(2):182-97
pubmed: 21981045
Cell. 2009 Oct 30;139(3):468-84
pubmed: 19879837
Mol Cell Biol. 1996 Mar;16(3):1212-9
pubmed: 8622665
J Virol. 2004 Jun;78(12):6420-30
pubmed: 15163735
Virology. 1998 Sep 30;249(2):406-17
pubmed: 9791031
Virus Res. 2007 Nov;129(2):73-9
pubmed: 17764774
J Virol. 2015 Mar;89(6):3123-35
pubmed: 25552726
Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1075-1080
pubmed: 29339477
Virology. 2005 Nov 10;342(1):150-8
pubmed: 16122776
Anal Biochem. 1995 Jan 1;224(1):451-5
pubmed: 7710111
Nucleic Acids Res. 2017 Jan 4;45(D1):D1107-D1111
pubmed: 27899654
J Virol. 2016 Apr 29;90(10):4914-4925
pubmed: 26937028
PLoS Pathog. 2010 Sep 16;6(9):e1001110
pubmed: 20862315
Antimicrob Agents Chemother. 2010 Aug;54(8):3179-86
pubmed: 20498328
Int J Biochem Cell Biol. 2017 Oct;91(Pt B):102-115
pubmed: 28552434
Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11329-33
pubmed: 16840555
J Virol. 2008 Dec;82(24):12569-73
pubmed: 18829754
J Virol Methods. 2010 Jul;167(1):31-6
pubmed: 20304016
J Virol. 2005 Feb;79(3):1898-905
pubmed: 15650213
J Virol. 2003 Feb;77(3):1764-71
pubmed: 12525610
J Virol. 2016 Jul 27;90(16):7481-7496
pubmed: 27279615

Auteurs

Yuki Takamatsu (Y)

Institut für Virologie, Philipps-Universität Marburg, Marburg, Germany.
Laboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.

Verena Krähling (V)

Institut für Virologie, Philipps-Universität Marburg, Marburg, Germany.
German Center of Infection Research (DZIF), Partner Site Giessen-Marburg-Langen, Marburg, Germany.

Larissa Kolesnikova (L)

Institut für Virologie, Philipps-Universität Marburg, Marburg, Germany.

Sandro Halwe (S)

Institut für Virologie, Philipps-Universität Marburg, Marburg, Germany.
German Center of Infection Research (DZIF), Partner Site Giessen-Marburg-Langen, Marburg, Germany.

Clemens Lier (C)

Institut für Virologie, Philipps-Universität Marburg, Marburg, Germany.

Stefan Baumeister (S)

Protein Analytics, Faculty of Biology, Philipps University Marburg, Marburg, Germany.

Takeshi Noda (T)

Laboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.

Nadine Biedenkopf (N)

Institut für Virologie, Philipps-Universität Marburg, Marburg, Germany.
German Center of Infection Research (DZIF), Partner Site Giessen-Marburg-Langen, Marburg, Germany.

Stephan Becker (S)

Institut für Virologie, Philipps-Universität Marburg, Marburg, Germany Becker@staff.uni-marburg.de.
German Center of Infection Research (DZIF), Partner Site Giessen-Marburg-Langen, Marburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH